Elevated eNAMPT-a DAMP and TLR4 ligand—in IPF patients correlates with severity and drives alveolar type II cell proliferation and EMT via TLR4, facilitating pathological remodeling (189). Here, TLR4 is linked to idiopathic pulmonary fibrosis.